Overview

Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
0
Participant gender:
Female
Summary
To compare effectiveness of oral labetalol and oral nifedipine for management of postpartum hypertension.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Dow University of Health Sciences
Treatments:
Labetalol
Nifedipine
Criteria
Inclusion Criteria:

- all women with postpartum hypertension as a continuation of pregnancy induced
hypertension,eclampsia, pre-eclampsia or new onset de-novo postpartum hypertension,of
any parity.

- age group between 18-48.

- after informed consent.

Exclusion Criteria:

- all women with chronic hypertension, uncontrolled and un treated medical disorders
will be excluded.

- conditions in which drugs labetalol and nifedipine is contraindicated.